NRNajmeh Ranji

Najmeh Ranji

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Najmeh Ranji has a total of 156 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Anti-biofilm and Efflux Pump Inhibitory Function of Fe3O4@SBA-3@Curcumin Nanoparticles on drug resistant isolates of Pseudomonas aeruginosa and Molecular Docking Analysis

    by Ali Pabousi Sadatmahale, Alireza Nouhi Kararoudi, Hossein Zahmatkesh, Hanieh Haghdoust Kooyshahi, Shahin Nezamivand Chegini, Seyed Reza Garakoui, Mahdi Shahriarinour, Mohammad Nikpassand, Najmeh Ranji

    Increased biofilm formation and efflux pumps activity are two major contributors to the antimicrobial resistance in clinical isolates of Pseudomonas aeruginosa (P. aeruginosa). In the present study, curcumin-functionalized Fe3O4 nanoparticles were synthesized and evaluated for their anti-biofilm and efflux pump inhibitory effects against P. aeruginosa. The nanoparticles, designated Fe3O4@SBA-3@Curcumin, were prepared via co-precipitation method followed by surface functionalization. Comprehensive physicochemical characterization was performed using thermal analysis and multiple spectroscopic techniques. The antimicrobial efficacy of Fe3O4@SBA-3@Curcumin alone and in combination with ciprofloxacin was assessed using fractional inhibitory concentration (FIC) analysis, biofilm formation assays, and pyocyanin production measurements. FT-IR spectroscopy confirmed successful curcumin functionalization without structural degradation. FE-SEM and TEM images demonstrated nanoparticle size of 52.12 nm and 32.20 nm, respectively. Dynamic light scattering (DLS) analysis revealed a mean particle diameter of 101.8 nm and excellent colloidal stability, as indicated by a zeta potential of -86.8 mV. Combination therapy exhibited a synergistic effect and significantly reduced biofilm formation and pyocyanin production. Furthermore, combined treatment with Fe₃O₄@SBA-3@Curcumin and ciprofloxacin resulted in downregulation of efflux pump genes (mexA, mexB, and oprM) and biofilm-associated genes (algD and pelA). Molecular docking analyses predicted favorable binding interactions between curcumin and key biofilm-related proteins involved in exopolysaccharide synthesis (algD and pelD), as well as efflux pump components associated with antibiotic resistance (mexB, mexA, and oprM) in P. aeruginosa. Collectively, these findings support the potential role of curcumin functionalization in attenuating biofilm formation and efflux pump activity. Overall, Fe₃O₄@SBA-3 nanoparticle may serve as an effective nanocarrier for targeted drug delivery into bacterial cells.

  • Open Access

    Anticancer effects of bisabolol oxide A-Loaded Micellar/Liposomal nanoparticles on DU-145 cells with deregulation of miR-34a and miR-181a: in silico and in vitro studies

    by Shirin Fekri Kohan, Zohreh Arefi Khorrami, Fatemeh Bahrevar Fatideh, Shahin Nezamivand Chegini, Alireza Nouhi Kararoudi, Hossein Zahmatkesh, Behnam Rasti, Mohammad Nikpassand, Mahdi Shahriarinour, Najmeh Ranji, et al.

    Bisabolol oxide A, a key bioactive constituent of Matricaria chamomilla, is recognized for its potent anti-inflammatory, antioxidant, and anticancer properties. This study focused on synthesizing bisabolol oxide A-loaded micellar/liposomal nanoparticles (NPs) and rigorously evaluating their anti-proliferative and anti-invasive effects using integrated in vitro and in silico methodologies. Physicochemical characterization of the bisabolol oxide A-loaded NPs was performed using SEM, TEM, TGA-DTG, Zeta potential, DLS analysis, and FT-IR spectroscopy. Furthermore, drug-like properties for bisabolol oxide A, bisabolol oxide B, and 5,8,11-heptadecatriynoic acid methyl ester were predicted using Swiss ADME software. Molecular dynamics simulations were subsequently conducted for these compounds against critical cellular migration proteins: β-catenin and the Epidermal Growth Factor Receptor (EGFR). The anticancer efficacy of the bisabolol oxide A-loaded nanoparticles was assessed through MTT assays, Annexin V/PI staining, wound healing assays, and qRT-PCR. Characterizations confirmed that the nanoparticles possessed optimal characteristics, exhibiting sizes between 35 to 67 nm, high mono-dispersity and thermal stability up to 380°C. In vitro results demonstrated that bisabolol oxide A-loaded micellar/liposomal nanoparticles significantly inhibited DU-145 cell proliferation, yielding IC₅₀ value of 55.44 µg/mL, 46.21 µg/mL, and 43.59 µg/mL after 24, 48, and 72 hours of treatment. Flow-cytometry analysis further confirmed 50.04% reduced migratory capacity and induction of apoptosis. Mechanistically, qRT-PCR analysis revealed a significant 2.31 ± 0.16-fold upregulation of the tumor-suppressive miR-34a and a 1.72 ± 0.03-fold downregulation of the oncomiR miR-181a in treated cells. These miRNA alterations correlated with the downregulation of migration-associated genes (CTNNB, SMAD3, and EGFR) and the upregulation of apoptosis-related genes (P53 and CASP9), findings substantiated by Western blot analysis. In silico analyses indicated favorable ADMET properties for bisabolol oxide A, bisabolol oxide B, and 5,8,11-heptadecatriyneoic acid methyl ester. Molecular docking simulations revealed strong binding affinities of these compounds for β-catenin and EGFR, which are key proteins in cellular migration pathways. Our findings strongly suggest that bisabolol oxide A functions as an anti-migration and pro-apoptotic agent by effectively modulating the expression of specific miRNAs and their transcriptional targets, complemented by potent inhibitory interactions with critical protein targets.

  • Open Access

    Anticancer activity of an apigenin-functionalized silica-coated silver oxide nanocomposite against human gastric adenocarcinoma cells (AGS): in vitro and in silico analysis

    by Seyed Milad Mousavi Eshkelani, Reyhaneh Kouchakinejad, Sara Dabirian, Parastoo Vakilinezami, Kamyab Shokrani, Hamed Tajmehri, Hossein Zahmatkesh, Mahdi Shahriarinour, Behnam Rasti, Mohammad Nikpassand, et al.

    Silver nanoparticles show promise anticancer agents, yet their clinical translation is hindered by poor bioavailability and nonspecific toxicity. In this s


  • Synthesis of stable micelle/liposome nanocarriers to deliver silibinin into ciprofloxacin resistant isolates of Escherichia coli with effects on biofilm formation and efflux pumps

    by Shayan Majlesi, Faten Divsar, Melika Moshiri Langroudi, Narjes Izee, Mahlagha Amin Malek, Sajjad Yousefipour, Seyed Javad Zendehrokh, Amirreza Mirdamadi, Zeinab Jafari, Hossein Zahmatkesh, et al.

    Silibinin-loaded micelle/liposome nanocarriers (SMLNs) were successfully synthesized and characterized using FT-IR, SEM, TEM, XRD and TGA analyses. The nanocarriers exhibited an average particle size of 16.33 nm as determined by TEM imaging and less than 60 nm by FE-SEM analysis. They displayed an amorphous structure, and high thermal stability, maintaining integrity at temperatures exceeding 650 °C. The silibinin loading content and entrapment efficiency were 3.2% and 83.3%, respectively. In vitro release studies demonstrated a rapid, pH-dependent release, achieving complete drug release within 60 min at pH 5.0 and 65 min at pH 7.4. The combination of SMLNs with ciprofloxacin produced strong synergistic antibacterial effects, reducing the minimum inhibitory concentration (MIC) of ciprofloxacin by 2- to 128-fold against resistant E. coli isolates. Biofilm formation decreased significantly under combination therapy compared with ciprofloxacin alone. Quantitative RT-PCR revealed that co-treatment downregulated efflux pump (acrA, acrB and tolC) and virulence (fimH and sfa) genes, while upregulating the repressor gene acrR. Molecular docking confirmed strong binding of silibinin to AcrAB-TolC, acrR, and fimH with binding affinities ranging from − 6.0 to − 8.9 kcal/mol.These findings demonstrate that SMLNs enhance the antibacterial efficacy of ciprofloxacin by inhibiting efflux pumps and biofilm formation, highlighting their potential as a multifunctional nanoplatform to combat antibiotic-resistant E. coli.


  • Design and Synthesis of a Novel Indole Derivative (2Cl-5N-ind-dione) and its Effect on miR-181a, miR-200a, and miR-34a Expression, Targeting Apoptosis, and Migration Pathways in HT-29 Colorectal Cancer Cells

    by M. Rasaei, E. Mohajeri, A. Sahranavard Siahmazgi, S. Nezamivand Chegini, S. Dabirian, H. Zahmatkesh, H. S. Kamalifar, B. Rasti, M. Shahriarinour, N. Ranji, et al.

    Objective: Indole, a nitrogen-containing heterocyclic compound, exhibits a range of pharmacological effects, including antimicrobial, anti-inflammatory, and anticancer properties. Colorectal cancer is a leading cause of cancer-related mortality worldwide. This study aimed to evaluate the antitumor activity of a newly synthesized indole derivative, 2-((2-chloro-5-nitrophenyl)(1H-indol-3-yl)methyl)-2H-indene-1,3-dione (designated as 2Cl-5N-ind-dione), on HT-29 colorectal adenocarcinoma cells. Methods: The novel compound 2Cl-5N-ind-dione was synthesized and its structure was confirmed by 1H, 13C NMR, and FT-IR spectroscopy. Its antitumor efficacy was assessed using the MTT assay, Annexin V/PI staining, and quantitative RT-PCR. Results and Discussion: Treatment with compound 2Cl-5N-ind-dione exerted cytotoxic effects on HT-29 cells with IC50 values of 70.54, 23.64, and 22.18 µg/mL at 24, 48, and 72 h, respectively. The compound modulated the expression of specific microRNAs: it upregulated the tumor-suppressive miRNAs miR-200a and miR-34a, while downregulating miR-181a. Wound healing assays, flow cytometry, and qRT-PCR analysis confirmed that 2Cl-5N-ind-dione inhibited cell migration and induced apoptosis in HT-29 cells compared to untreated controls. Conclusions: Our data indicate that compound 2Cl-5N-ind-dione acts as an anti-proliferative, antimigratory, and pro-apoptotic agent. These effects are likely mediated by the observed modulation of miR-200a, miR-34a, and miR-181a, which are known to target key pathways involved in apoptosis and cell migration.


  • Anti-Invasion and Apoptotic Induction Effects of Quercetin-Functionalized Silver Oxide (Ag2O) Nanoparticles on DU-145 Prostate Carcinoma Cells via Modulation of miR-34a, miR-181a, and Their Potential Targets

    by S. M. Mousavi Eshkelani, A. Sejdeh Hassankiadeh, M. Hajitabar, Z. Shamsi Balasbaneh, T. Kazemi, H. Beheshti Dafchahi, M. Shahriarinour, M. Nikpassand, N. Ranji, R. S. Varma

    Objective: Quercetin, a flavonoid found in fruits and vegetables, is known for its antioxidant, anti-inflammatory, and cytotoxic properties. However, its poor water solubility limits its therapeutic potential. This study aimed to design and synthesize a nanocomposite for efficient quercetin delivery to DU-145 prostate carcinoma cells and evaluate its therapeutic effects. Methods: Ag2O@Quercetin nanoparticles (Ag2O@Quercetin NCs) were designed and synthesized to enhance the delivery of insoluble quercetin to DU-145 cells. The anti-tumor activities of the nanoparticles were evaluated using the MTT assay, Annexin V FITC/PI staining, scratch assay, and analysis of miR-34a and miR-181a expression patterns, along with their potential targets in cell migration and apoptosis via quantitative RT-PCR (Q-RT-PCR). Results and Discussion: Physicochemical characterization, including X-ray diffraction (XRD), transmission electron microscopy (TEM), field emission scanning electron microscopy (FE-SEM), differential thermal gravimetric (DTG) analysis, and FT-IR spectroscopy, confirmed the particle size, elemental composition, and thermal stability of the Ag2O@Quercetin NCs. The nanoparticles exhibited antiproliferative activity, with an IC50 value of 55.27 µg/mL in DU-145 cells. The scratch assay demonstrated that Ag2O@Quercetin NCs inhibited cancer cell migration. Upregulation of miR-34a and downregulation of its potential targets, EGFR and TGF-β1, were observed in treated cells. Additionally, downregulation of oncomiR-181a and upregulation of their potential targets involved in apoptosis (Casp8 and Casp9 genes) and anti-invasion (E-cadherin) were observed in treated cells. Conclusions: The results indicate that silver oxide nanoparticles are effective carriers for quercetin delivery to cancer cells. Ag2O@Quercetin NCs induce apoptotic pathways and inhibit cell migration and invasion in prostate cancer cells through the modulation of specific miRNAs and their associated targets.


  • Open Access

    N-Acetylcysteine as an anti-oxidant and anti-inflammatory agent in decreasing histopathological damages and oxidative stress after mercury exposure in lung tissue of rats

    by Kebria Diako, Shadi Rahimi, Seyed Ali Mirbagheri Saghaleksari, Seyed Milad Mousavi Eshkelani, Niloofar Keshavarz Taramsari, Asghar Beigi Harchegani, Zhaleh Mohsenifar, Mahdi Shahriarinour, Najmeh Ranji

    Mercury (Hg) is a naturally occurring heavy metal with high toxicitythat affects various organs. This study aimed to evaluate the protective effects of N-acetylcysteine (NAC) on the lung tissue of Wistar rats exposed to mercury. Rats were divided into five groups: H1 (control), H2 (single dose of Hg), H3 (continuous dose of Hg), H4 (single dose of Hg+ single dose of NAC), and H5 (continuous dose of Hg+ continuous dose of NAC). The expression levels of SOD1, NOS, TIMP1, Fibronectin1, HIF1, MPO, MMP2 and TIMP2 were analyzed using qRT-PCR. Mercury levels in the blood and lung tissues significantly increased in the H2 and H3 groups compared to the H4 and H5 groups, respectively. Hg exposure in H3 group significantly (P < 0.001) led to the upregulation of MPO (4.55-fold), HIF1(4.31-fold), MMP2 (4.20-fold), TIMP1(3.18-fold), TIMP2 (4.83-fold), NOS (3.52-fold), and FN1 (3.52-fold), along with the downregulation of SOD1 (0.51-fold) compare to control group (H1). In contrast, rats treated with NAC after Hg exposure in H5 group significantly (p < 0.01–0.001) showed downregulation of MPO (2.49-fold), HIF1(2.12-fold), MMP2 (1.94-fold), TIMP1(1.92-fold), TIMP2 (1.96-fold), NOS (2.00-fold), and FN1 (1.90-fold), and upregulation of SOD1 (0.76-fold) compare to H3 group. A significant reduction in mercury levels was also observed in the blood and lung tissue of rats treated with NAC compared to those exposed Hg alone. NAC exerts a protective effect against mercury-induced cytotoxicity and genotoxicity in rat lungs by scavenging mercury and modulating the expression of oxidative stress-related genes.


  • Anti-bacterial activity of silibinin-functionalized silica-coated Fe3O4 magnetic nanocomposites on Pseudomonas aeruginosa

    by Nazanin Pasandideh Kordmahaleh, Mirsasan Mipour, Najmeh Ranji, Mahdi Shahriarinour, Mohammad Nikpassand

    The nanocomposites were synthesized and characterized using Fourier transform infrared spectroscopy (FT-IR), thermogravimetric analysis (TGA), transmission electron microscopy (TEM), field emission scanning electron microscopy (FE-SEM), and X-ray diffraction (XRD). The physicochemical analyses confirmed the structural integrity, uniform particle size (34–58 nm), thermal stability (> 600 °C), and magnetic properties of the nanocomposites. The nanocomposites exhibited strong synergistic effects with ciprofloxacin, reducing the minimum inhibitory concentration (MIC) in combination by 4- to 16-fold compared to ciprofloxacin alone. Furthermore, the nanocomposites in combination with ciprofloxacin significantly inhibited biofilm formation in clinical isolates. The gene expression analysis revealed downregulation of key efflux pump genes (mexX, mexY, and oprM), resulting to increased intracellular accumulation of ciprofloxacin. This mechanism potentiated the bactericidal effects of ciprofloxacin, even against resistant strains. These findings highlight the potential of Fe3O4@SPN@Silibinin as a biodegradable, stable, and water-soluble nanocarrier for silibinin delivery, offering a novel therapeutic strategy for combat multidrug-resistant bacterial infections. This study presents a promising approach to addressing the growing threat of antibiotic resistance through targeted drug delivery and genetic modulation.


  • The neuroprotective effects of nanocurcumin on Parkinson’s disease markers in rats exposed to tin chloride

    by Saedolah Golmoradi, Najmeh Ranji, Mahdi Shahriarinour, Eisa Vefghi

    Tin chloride, a heavy metal compound, induces neurotoxicity and is associated with Parkinson’s disease (PD), a condition characterized by inflammation and oxidative stress. Curcumin, a polyphenolic compound, is widely recognized for its antioxidant and anti-inflammatory properties. This study examined the neuroprotective effects of nanocurcumin in a rat model of PD induced by tin (II) chloride. 20 Wistar rats were randomly assigned to four groups (n = 5/group): control, nanocurcumin (20 mg/kg), tin chloride, and tin chloride + nanocurcumin. After 4 weeks, brain tissues were analyzed histologically and for expression of inflammatory markers (IL-6, MCP-1, α-synuclein). Serum levels of superoxide dismutase (SOD), malondialdehyde (MDA), calcium (Ca2⁺), and tin were also measured. Nanocurcumin significantly attenuated tin-induced neuroinflammation and neuronal damage. Treated rats showed downregulation of IL-6, MCP-1, and α-synuclein expression (P < 0.05), increased SOD activity, and decreased MDA levels (P < 0.05). Serum Ca2⁺ levels were elevated in the nanocurcumin group, potentially reflecting reduced accumulation in brain tissues. Nanocurcumin mitigates tin chloride-induced neurotoxicity via antioxidant and anti-inflammatory mechanisms, indicating its potential as a therapeutic candidate for Parkinson’s disease.

  • Open Access

    Silibinin‐Loaded Nanoparticles for Drug Delivery in Gastric Cancer: In Vitro Modulating miR‐181a and miR‐34a to Inhibit Cancer Cell Growth and Migration

    by Mohsen Karami Fath, Parastoo Vakilinezami, Zohre Abdoli Keleshtery, Zahra Sima Azgomi, Sharareh Nezamivand Chegini, Mahdi Shahriarinour, Saman Seyfizadeh Saraabestani, Mahzad Diyarkojouri, Mohammad Nikpassand, Najmeh Ranji

    Silibinin (C25H22O10), a notable bioactive flavonolignans, is recognized for its anticancer properties. However, due to its poor water solubility, the objective of this study was to design and synthesize nanocarriers to enhance the solubility of silibinin for effective delivery to AGS gastric cancer cells. This study details the synthesis of PEG400‐OA nanoparticles for silibinin delivery to AGS cells. Various physicochemical techniques, including FT‐IR, TGA, EDX, FE‐SEM, and TEM, were employed to characterize the silibinin‐loaded nanoparticles (SLNs), confirming particle size, elemental composition, thermal stability, and paramagnetic properties. The anticancer effects of the SLNs were assessed using MTT assay, scratch test, and Q‐RT‐PCR. The SLNs exhibited particle sizes ranging from 45 to 60 nm, with thermal stability below 110°C. TEM images suggested a micelles/liposomes structure due to the low polydispersity and spherical shape of the particles. EDX analysis revealed the presence of C, O, N, and P, confirming the incorporation of phospholipids (micelle/liposome) within the SLNs. The IC50 of SLNs in AGS cells was determined to be 28.21 μg/mL. Antimigration effects of SLNs's were demonstrated through the downregulation of miR‐181a and upregulation of its potential targets (TGFB, SMAD3, and β‐catenin genes), as well as the upregulation of miR‐34a and downregulation of its potential target (E‐Cadherin antimigration gene). The findings suggest that nanoparticles serve as effective nanocarriers for the targeted delivery of silibinin to cancer cells. Silibinin‐loaded micelles/liposomes nanoparticles (SLNs) appear to inhibit cancer cell proliferation and migration by modulating the expressionof miRNAs and their target mRNAs.